VJHemOnc is committed to improving our service to you

CAR-T ICU 2019 | CAR-T side effects: CRS, neutropenic fever & MAS/HLH

VJHemOnc is committed to improving our service to you

Sandrine Valade

Sandrine Valade, MD, Saint-Louis University Hospital, Paris, France, discusses the prevalence of adverse events in CAR-T treated patients, and the challenges of distinguishing between them. She covers cytokine release syndrome (CRS), neutropenic fever, and macrophage activation syndrome (MAS) and hemophagocytic lymphohistiocytosis (HLH). This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter